3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
2
Gastrointestinal
2
Thoracic
1
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
21
Lung Neoplasms
13
Neoplasms
3
Small Cell Lung Carcinoma
2
Ovarian Neoplasms
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Cancer Extensive Stage
1
Skin Neoplasms
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Pneumonia
1
Peritoneal Neoplasms
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma
1
Lymphoma
1
Lung Diseases, Interstitial
1
Liver Neoplasms
1
Leukemia
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Frailty
1
Interventions
Cisplatin
4
Fluorouracil
3
Oxaliplatin
2
Leucovorin
2
Hyperthermic Intraperitoneal Chemotherapy
2
Cytoreduction Surgical Procedures
2
Carboplatin
2
130-nm albumin-bound paclitaxel
2
tremelimumab
1
pembrolizumab
1
durvalumab
1
cc-486
1
Surgical Procedures, Operative
1
Paclitaxel
1
Observation
1
Mitomycin
1
Ifosfamide
1
Gemcitabine
1
EC regimen
1
Doxorubicin
1
CP protocol
1
Azacitidine
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Peritoneal Neoplasms
×
Observation
×
Thoracic
×
Clear all
NCT02073500
2021-07-28
PSM
Oslo University Hospital
Recruiting
300 enrolled